July 17, 2023
New Alzheimer's Drug Donanemab: Coverage in U.S. Media and Think Tanks
EdgeTheory
A new drug, Donanemab, developed by Eli Lilly, has shown promise in slowing the progression of early-stage Alzheimer's disease and is expected to receive FDA approval in the fall.